Author: digi

Managing Consumables (Wipes, Mops, Garments) in CCS and EM Programs Comprehensive Guide: Managing Consumables in Contamination Control and Environmental Monitoring Programs In sterile pharmaceutical manufacturing environments, particularly in aseptic manufacturing, the proper management of consumables such as wipes, mops, and garments is critical for maintaining sterility assurance and compliance with Annex 1 requirements. This step-by-step…

Read More “Managing Consumables (Wipes, Mops, Garments) in CCS and EM Programs” »

Long-Term Trending of CCS Effectiveness: What to Track and How Often Long-Term Trending of Contamination Control Strategy Effectiveness in Aseptic Manufacturing The pharmaceutical industry’s commitment to sterility assurance and contamination control is exemplified by stringent regulatory frameworks such as Annex 1 of the EU GMP guidelines. A critical component advancing manufacturing quality is the long-term…

Read More “Long-Term Trending of CCS Effectiveness: What to Track and How Often” »

Auditing Contamination Control Measures at CMOs and Fill–Finish Partners Step-by-Step Guide to Auditing Contamination Control Measures in Aseptic Manufacturing at CMOs and Fill–Finish Partners Contract Manufacturing Organizations (CMOs) and fill–finish partners are integral to the sterile manufacturing supply chain. Ensuring robust contamination control systems at these external partners is paramount to maintaining sterility assurance and…

Read More “Auditing Contamination Control Measures at CMOs and Fill–Finish Partners” »

Using Third-Party Microbiology and EM Vendors Without Losing Control Effective Management of Third-Party Microbiology and Environmental Monitoring Vendors in Sterile Manufacturing Outsourcing microbiology and environmental monitoring (EM) services in aseptic manufacturing is a common practice within the pharmaceutical industry’s US, UK, and EU sectors. However, relying on third-party vendors for critical contamination control activities, especially…

Read More “Using Third-Party Microbiology and EM Vendors Without Losing Control” »

Temporary Facilities and Pilot Plants: Contamination Control Expectations Comprehensive Guide to Contamination Control in Temporary Facilities and Pilot Plants for Aseptic Manufacturing The pharmaceutical industry’s increasing reliance on temporary facilities and pilot plants for aseptic manufacturing places heightened focus on contamination control measures. Ensuring compliance with regulatory expectations as outlined in Annex 1 to the…

Read More “Temporary Facilities and Pilot Plants: Contamination Control Expectations” »

CCS for Non-Classical Modalities: Viral Vectors, Vaccines and Biologics Comprehensive CCS for Non-Classical Modalities: Viral Vectors, Vaccines and Biologics The manufacture of non-classical pharmaceutical modalities such as viral vectors, vaccines, and biologics presents unique contamination control and sterility assurance challenges. Applicable regulations and guidances—including ICH Q9 on Quality Risk Management, FDA 21 CFR Part 211,…

Read More “CCS for Non-Classical Modalities: Viral Vectors, Vaccines and Biologics” »

Contamination Control at Interfaces Between Classified and Non-Classified Areas Effective Contamination Control at Interfaces Between Classified and Non-Classified Areas in Aseptic Manufacturing Maintaining contamination control within pharmaceutical aseptic manufacturing environments is essential to ensuring patient safety, product sterility, and regulatory compliance. A critical aspect of contamination control is the management of interfaces between classified cleanrooms…

Read More “Contamination Control at Interfaces Between Classified and Non-Classified Areas” »

Handling Deviations From Standard Gowning or Entry Procedures Step-by-Step Guide: Handling Deviations from Standard Gowning or Entry Procedures in Aseptic Manufacturing In pharmaceutical aseptic manufacturing, proper gowning and entry procedures are fundamental to maintaining critical contamination control and safeguarding product sterility assurance. Deviations from these established procedures pose risks to cleanroom integrity and may lead…

Read More “Handling Deviations From Standard Gowning or Entry Procedures” »

Impact of Human Resource Constraints on Contamination Control and Annex 1 Risk How Human Resource Constraints Affect Contamination Control and Annex 1 Compliance in Aseptic Manufacturing Ensuring effective contamination control in aseptic manufacturing remains a core objective amid the evolving challenges encountered within pharmaceutical production environments. Human resources (HR) play a critical role in maintaining…

Read More “Impact of Human Resource Constraints on Contamination Control and Annex 1 Risk” »

Aligning CCS With Site Master File, VMP and PQS Documentation Step-by-Step Guide to Aligning Contamination Control Strategy With Site Master File, VMP and PQS Documentation Effective contamination control is the cornerstone of aseptic manufacturing and sterility assurance in pharmaceutical production. Harmonizing your contamination control strategy (CCS) with the Site Master File (SMF), Validation Master Plan…

Read More “Aligning CCS With Site Master File, VMP and PQS Documentation” »